Dorval, Quebec–(Newsfile Corp. – October 25, 2022) – West Island Brands Inc. (CSE: WIB) (FSE: 39N0) (OTC Pink: WIBFF) (“West Island” or the “Company”) is pleased to report that subsidiary RoyalMax Biotechnology Canada Inc. D.B.A. West Island Culture (“West Island”) has received the amendment to the Company’s Health Canada license permitting the sale of cannabis extracts, including hashish, as per Cannabis 2.0. West Island is now authorized to process and sell Cannabis 2.0 products directly to provincial distributors and other authorized Canadian retail supply channels.

West Island Culture continues to work closely with Montreal-based hashish and concentrates maker, Oaziz Extracts Inc. (“Oaziz”). Oaziz and West Island are working together to develop and produce exceptional solventless craft cannabis extracts to be sold to all authorized provincial retailers and distributors.

West Island COO, Meissam Hagh Panah, states, “The demand for hash and, resins and rosins is high, but supply is limited due to the small number of producers delivering a consistent and quality product. Even more popular are infused prerolls, which are the fastest growing segment of the market. Through our partner Oaziz, West Island will bring premium Montreal made hash offerings to the market. We will also bring infused prerolls and other concentrates to consumers eager for quality and innovation.”

About West Island
West Island is a multi-faceted, innovative company in the Quebec cannabis space. Its subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A West Island Culture is a Montreal, Quebec based cannabis company. A Health Canada Licence Holder West Island has standard cultivation licence, standard processing, medical sales and sales licences.

For more information on West Island Brands please visit the website at: westislandbrands.com. West Island cannabis products can be found in British Columbia, Saskatchewan, Manitoba, Northwest Territories, Ontario and Quebec.

On behalf of the Board of Directors
WEST ISLAND BRANDS INC.
Boris Ziger
Boris Ziger, CEO & Chairman

The Company’s public filings are available for review at www.sedar.com and www.thecse.com.

For further information, please contact:
Boris Ziger, CEO at:
Telephone: 416-304-9935
E-mail: [email protected]
Website: www.westislandbrands.com

Boris Ziger, PDG de :
Téléphone : 416-304-9935
Courriel : [email protected]
Site Web : www.westislandbrands.com

Disclaimer for Forward-Looking Information

Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. The Corporation assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Corporation. Additional information identifying risks and uncertainties is contained in the Corporation’s filings with the Canadian securities regulators, which filings are available at www.sedar.com.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek Safe Harbor.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/141728